Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men

Urology

Volumn 47, Issue 1, 1996, Pages 38-42

  Lepor, Herbert ^a   Shapiro, Ellen ^b   Wang, Bo ^b   Liang, Yong Cheng ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ACTIN;

ARTICLE; CAUCASIAN; CELL COMPOSITION; CHINESE; CLINICAL ARTICLE; CONNECTIVE TISSUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SMOOTH MUSCLE;

EID: 0030053612     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80379-3     Document Type: Article

References (17)

1. Berry SJ, Coffey DS, Walsh PC, and Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol 132: 474-479, 1984.
2. Guess HA, Arrighi HM, Metter EJ, and Fozard JL: Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 17: 241-246, 1990.
3. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, and Lieber MM: The prevalence of prostatism: a population based survey of urinary symptoms. J Urol 150: 85-89, 1993.
4. Isaacs JT, and Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate 2: 33-50, 1989.
5. Terres MK, and Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 145: 984, 1981.
6. Wennberg J, and Gittelsohn A: Variations in medical care among small areas. Sci Am 246: 120-134, 1982.
7. Conger KB: Racial incidence of prostatism in Hawaii: a report of 172 consecutive cases. J Urol 58: 444-447, 1947.
8. Shapiro E, Becich MJ, Hartanto V, and Lepor H: The relative proportion of stromal and epithelial hyperplasia is related to the development of clinical benign prostate hyperplasia. J Urol 147: 1293-1297, 1992.
9. Shapiro E, Hartanto V, and Lepor H: The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 21: 297-307, 1992.
10. Shapiro E, Hartanto V, and Lepor H: Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J Urol 147: 1167-1170, 1992.
11. Shapiro E, Hartanto V, and Lepor H: Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle. Prostate 20: 259-267, 1992.
12. McNeal JE: Origin and evolution of benign prostatic enlargement. Invest Urol 15: 340-345, 1978.
13. Strandberg JD: Comparative pathology of benign prostatic hyperplasia, in Lepor H, and Lawson RK (Eds): Prostatic Diseases. Philadelphia, WB Saunders, 1993, pp 212-225.
14. DeKlerk DP, Coffey DS, Ewing LL, McDermott IR, Reiner WG, Robinson CH, Scott WW, Strandberg JD, Talalay P, Walsh PC, et al: Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 64: 842-849, 1979.
15. McNeal JE: The zonal anatomy of the prostate. Prostate 2: 35-49, 1981.
16. 1 adrenoceptors and area density of smooth muscle in the canine prostate. J Urol 148: 1310-1313, 1992.
17. Berry SJ, Coffey DS, Strandberg JD, and Ewing LL: Effect of the age, castration, and testosterone replacement in the development and restoration of canine benign prostatic hyperplasia. Prostate 9: 295-302, 1986.